COVID-19 Incidence and Vaccine Effectiveness in University Staff, 1 March 2020-2 April 2022

被引:6
作者
Cegolon, Luca [1 ,2 ]
Negro, Corrado [1 ,2 ]
Pesce, Marco [1 ]
Filon, Francesca Larese [1 ,2 ]
机构
[1] Univ Trieste, Dept Med, Surg & Hlth Sci, I-34129 Trieste, Italy
[2] Univ Trieste, Dept Med Surg & Hlth Sci, Clin Unit Occupat Med, I-34129 Trieste, Italy
关键词
SARS-CoV-2; COVID-19; incidence; vaccine effectiveness; booster dose; university staff; healthcare workers; WORKPLACE OUTBREAKS; INDUSTRY SECTOR; WORKERS; RISK;
D O I
10.3390/vaccines11020483
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: University workers undergo intense social interactions due to frequent contact with students and colleagues and lectures in crowdy conditions. The aim of our study was to assess the incidence of COVID-19 infection and vaccine effectiveness in a cohort of workers of the University of Trieste from 1 March 2020 (start of the pandemic) through 2 April 2022. Methods: The University of Trieste implemented a number of public health policies to contain the spread of SARS-CoV-2 on the campus, including prompt contact tracing, enhanced ventilation of all premises, fomites disinfection and mandatory use of face masks indoors. In compliance with the surveillance protocol of the local public health department, university personnel were tested for SARS-CoV-2 by polymerase chain reaction (PCR) on a nasopharyngeal swab on demand, in the event of symptoms consistent with COVID-19 or for contact tracing, following close contact with a confirmed COVID-19 case. The incidence rates of SARS-CoV-2 infections were estimated as number of cases by number of person-days (p-d) at risk. Multivariable Cox proportional hazard regression model was employed to investigate the risk of primary COVID-19 infection, controlling for a number of potential confounders and expressing the risk as the adjusted hazard ratio (aHR) with a 95% confidence interval (95% CI). Results: The incidence of SARS-CoV-2 infection among university staff was lower than that of healthcare workers (HCWs) of the same area. Compared to unvaccinated colleagues (6.55 x 10,000 p-d), the raw incidence of SARS-CoV-2 infection was higher among university workers immunized with one (7.22 x 10,000 p-d) or two (7.48 x 10,000 p-d) doses of COVID-19 vaccines, decreasing in those receiving the booster (1.98 x 1000 p-d). The risk of infection increased only in postgraduate medical trainees (aHR = 2.16; 95% CI: 1.04; 4.48), though this was limited to the Omicron transmission period. After the implementation of the national vaccination campaign against COVID-19, workers immunized with the booster were less likely than unvaccinated workers to be infected by SARS-CoV-2 both before (aHR = 0.10; 95% CI: 0.06; 0.16) and after (aHR = 0.37; 95% CI: 0.27; 0.52) the Omicron transmission period. Vaccine effectiveness of the booster was 90% (=(1-0.10) x 100) before versus 63% (=(1-0.37) x 100) during the Omicron wave, without a significant difference between homologous (three doses of m-RNA vaccines) and heterologous immunization (first two doses of Vaxzevria followed by a third dose of m-RNA vaccine). Conclusions: The incidence of SARS-CoV-2 infection in university staff was lower than that of HCWs of ASUGI, likely because the testing-on-demand schedule inevitably missed the vast majority of asymptomatic infections. Therefore, the observed significantly protective effect of the booster dose in university personnel referred to symptomatic SARS-CoV-2 infections. The infection prevention and control policies implemented by the University of Trieste managed to equalize the biological risk between administrative and teaching staff.
引用
收藏
页数:18
相关论文
共 40 条
[1]  
Andrews N, 2022, NEW ENGL J MED, V386, P1532, DOI [10.1056/NEJMoa2119451, 10.1016/S1473-3099(22)00309-7]
[2]   Omicron variant of SARS-CoV-2: Genomics, transmissibility, and responses to current COVID-19 vaccines [J].
Araf, Yusha ;
Akter, Fariya ;
Tang, Yan-dong ;
Fatemi, Rabeya ;
Parvez, Md Sorwer Alam ;
Zheng, Chunfu ;
Hossain, Md Golzar .
JOURNAL OF MEDICAL VIROLOGY, 2022, 94 (05) :1825-1832
[3]  
autonomy.worK, JOBS RISK INDEX JARI
[4]   Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine [J].
Baden, Lindsey R. ;
El Sahly, Hana M. ;
Essink, Brandon ;
Kotloff, Karen ;
Frey, Sharon ;
Novak, Rick ;
Diemert, David ;
Spector, Stephen A. ;
Rouphael, Nadine ;
Creech, C. Buddy ;
McGettigan, John ;
Khetan, Shishir ;
Segall, Nathan ;
Solis, Joel ;
Brosz, Adam ;
Fierro, Carlos ;
Schwartz, Howard ;
Neuzil, Kathleen ;
Corey, Larry ;
Gilbert, Peter ;
Janes, Holly ;
Follmann, Dean ;
Marovich, Mary ;
Mascola, John ;
Polakowski, Laura ;
Ledgerwood, Julie ;
Graham, Barney S. ;
Bennett, Hamilton ;
Pajon, Rolando ;
Knightly, Conor ;
Leav, Brett ;
Deng, Weiping ;
Zhou, Honghong ;
Han, Shu ;
Ivarsson, Melanie ;
Miller, Jacqueline ;
Zaks, Tal .
NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (05) :403-416
[5]   Risk of Vaccine Breakthrough SARS-CoV-2 Infection and Associated Factors in Healthcare Workers of Trieste Teaching Hospitals (North-Eastern Italy) [J].
Basso, Paolo ;
Negro, Corrado ;
Cegolon, Luca ;
Larese Filon, Francesca .
VIRUSES-BASEL, 2022, 14 (02)
[6]   Racial and Ethnic Disparities Among COVID-19 Cases in Workplace Outbreaks by Industry Sector - Utah, March 6-June 5, 2020 [J].
Bui, David P. ;
McCaffrey, Keegan ;
Friedrichs, Michael ;
LaCross, Nathan ;
Lewisl, Nathaniel M. ;
Sage, Kylie ;
Barbeau, Bree ;
Vilven, Dede ;
Rose, Carolyn ;
Braby, Sara ;
Willardson, Sarah ;
Carter, Amy ;
Smoot, Christopher ;
Winquist, Andrea ;
Dunn, Angela .
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2020, 69 (33) :1133-1138
[7]   Nasal disinfection for the prevention and control of COVID-19: A scoping review on potential chemo-preventive agents [J].
Cegolon, L. ;
Javanbakht, M. ;
Mastrangelo, G. .
INTERNATIONAL JOURNAL OF HYGIENE AND ENVIRONMENTAL HEALTH, 2020, 230
[8]   Investigating hypothiocyanite against SARS-CoV-2 [J].
Cegolon, L. .
INTERNATIONAL JOURNAL OF HYGIENE AND ENVIRONMENTAL HEALTH, 2020, 227
[9]   In vitro antiviral activity of hypothiocyanite against A/H1N1/2009 pandemic influenza virus [J].
Cegolon, L. ;
Salata, C. ;
Piccoli, E. ;
Juarez, V. ;
Palu', G. ;
Mastrangelo, G. ;
Calistri, A. .
INTERNATIONAL JOURNAL OF HYGIENE AND ENVIRONMENTAL HEALTH, 2014, 217 (01) :17-22
[10]   Supporting the Aspecific Physiological Defenses of Upper Airways against Emerging SARS-CoV-2 Variants [J].
Cegolon, Luca ;
Mastrangelo, Giuseppe ;
Bellizzi, Saverio ;
Filon, Francesca Larese ;
Salata, Cristiano .
PATHOGENS, 2023, 12 (02)